Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results
Tenon Medical (NASDAQ:TNON), a company focused on treating sacroiliac joint disorders, has announced the timing of its second quarter 2024 financial results. The company will release its financial results for the quarter ended June 30, 2024, after market close on Tuesday, August 13, 2024. This will be followed by a conference call at 4:30 p.m. Eastern Time on the same day to discuss the results in detail and conduct a Q&A session with covering analysts. Investors can join the call via phone or webcast, with dial-in numbers provided for both domestic and international participants. An audio replay will be available until August 27, 2024, through Tenon's Investor Relations website or via telephone.
Tenon Medical (NASDAQ:TNON), un'azienda focalizzata sul trattamento dei disturbi dell'articolazione sacroiliaca, ha annunciato la data di pubblicazione dei risultati finanziari del secondo trimestre 2024. L'azienda rilascerà i risultati finanziari per il trimestre chiuso il 30 giugno 2024, dopo la chiusura del mercato martedì 13 agosto 2024. Seguirà una telefonata di conferenza alle 16:30 ora orientale dello stesso giorno per discutere i risultati in dettaglio e condurre una sessione di domande e risposte con gli analisti presenti. Gli investitori possono unirsi alla chiamata tramite telefono o webcast, con numeri di accesso forniti sia per i partecipanti nazionali che internazionali. Una registrazione audio sarà disponibile fino al 27 agosto 2024, attraverso il sito web delle relazioni con gli investitori di Tenon o tramite telefono.
Tenon Medical (NASDAQ:TNON), una empresa centrada en el tratamiento de trastornos de la articulación sacroilíaca, ha anunciado la fecha de sus resultados financieros del segundo trimestre de 2024. La empresa publicará sus resultados financieros para el trimestre que finalizó el 30 de junio de 2024, después del cierre del mercado el martes 13 de agosto de 2024. Esto será seguido por una videoconferencia a las 4:30 p.m. hora del Este el mismo día para discutir los resultados en detalle y realizar una sesión de preguntas y respuestas con los analistas que cubren. Los inversores pueden unirse a la llamada a través del teléfono o por webcast, con números de acceso proporcionados tanto para participantes nacionales como internacionales. Una grabación de audio estará disponible hasta el 27 de agosto de 2024, a través del sitio web de relaciones con inversores de Tenon o por teléfono.
테논 메디컬(TENON Medical)(NASDAQ:TNON)은 천장 관절 장애 치료에 집중하는 회사로 2024년 2분기 재무 결과 발표 일정을 2024년 8월 13일 화요일 장 마감 후 발표한다고 발표했습니다. 회사는 2024년 6월 30일 종료된 분기 간 재무 결과를 발표할 예정이며, 동일한 날 동부 표준시 오후 4시 30분에 결과를 자세히 논의하고 분석가와 질의응답 세션을 진행하기 위해 컨퍼런스 콜이 이어집니다. 투자자는 전화나 웹캐스트를 통해 콜에 참여할 수 있으며, 국내 및 국제 참가자를 위한 전화 접속 번호가 제공됩니다. 오디오 재생은 2024년 8월 27일까지 테논의 투자자 관계 웹사이트 또는 전화를 통해 이용할 수 있습니다.
Tenon Medical (NASDAQ:TNON), une entreprise spécialisée dans le traitement des troubles de l'articulation sacro-iliaque, a annoncé la date de publication de ses résultats financiers pour le deuxième trimestre 2024. L'entreprise publiera ses résultats financiers pour le trimestre clos le 30 juin 2024, après la clôture du marché le mardi 13 août 2024. Cela sera suivi d'une conférence téléphonique à 16h30, heure de l'Est le même jour pour discuter des résultats en détail et conduire une session de questions-réponses avec les analystes. Les investisseurs peuvent rejoindre l'appel par téléphone ou par webinaire, des numéros d'accès étant fournis pour les participants nationaux et internationaux. Une rediffusion audio sera disponible jusqu'au 27 août 2024, via le site Web des relations investisseurs de Tenon ou par téléphone.
Tenon Medical (NASDAQ:TNON), ein Unternehmen, das sich auf die Behandlung von Sakroiliakalgelenksstörungen konzentriert, hat den Termin für seine finanziellen Ergebnisse des zweiten Quartals 2024 bekannt gegeben. Das Unternehmen wird seine finanziellen Ergebnisse für das am 30. Juni 2024 endende Quartal nach Handelsschluss am Dienstag, den 13. August 2024, veröffentlichen. Anschließend findet am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz statt, um die Ergebnisse im Detail zu diskutieren und eine Frage- und Antwortrunde mit den analysierenden Analysten abzuhalten. Investoren können sich telefonisch oder per Webcast an dem Anruf beteiligen, wobei Zugangsdaten sowohl für inländische als auch für internationale Teilnehmer bereitgestellt werden. Eine Audioaufzeichnung wird bis zum 27. August 2024 über die Website der Investorenbeziehungen von Tenon oder per Telefon verfügbar sein.
- None.
- None.
LOS GATOS, CA / ACCESSWIRE / July 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the second quarter 2024 ended June 30, 2024 after market close on Tuesday, August 13, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
Date: | Tuesday, August 13, 2024 |
Time: | 4:30 p.m. Eastern time |
Dial-in: | 1-877-407-0792 |
International Dial-in: | 1-201-689-8263 |
Webcast: |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through August 27, 2024, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13747648.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran® SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran® Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran® SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit https://www.tenonmed.com/.
The Tenon Medical logo, Tenon Medical and Catamaran are registered trademarks of Tenon Medical, Inc.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View the original press release on accesswire.com
FAQ
When will Tenon Medical (TNON) release its Q2 2024 financial results?
What time is Tenon Medical's (TNON) Q2 2024 earnings conference call?
How can investors access Tenon Medical's (TNON) Q2 2024 earnings call?
Until when will the replay of Tenon Medical's (TNON) Q2 2024 earnings call be available?
